Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEUROPROTECT post-cardiac arrest trial
2015-002151-10Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Jun 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dobutamine, isoprenaline, norepinephrine and metoprolol in cardiac arrest (SCA) and hypoxic-ischemic encephalopathy (HIE) (2 arms), sponsored by UZ Leuven. Primary endpoint: Regional ADC scores. Started Jun 2015; status: completed.
02
Drugs
dobutamineisoprenalinenorepinephrinemetoprolol
03
Conditions
cardiac arrest (SCA)hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on 2015-002151-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002151-10.